MétaCan
Menu
Back to cohort

Defining Strategies of Modulation of Antiplatelet Therapy in Patients With Coronary Artery Disease: A Consensus Document from the Academic Research Consortium

2023· review· en· W4381192819 on OpenAlexafffund
Davide Capodanno, Roxana Mehran, Mitchell W. Krucoff, Usman Baber, Deepak L. Bhatt, Piera Capranzano, Jean‐Philippe Collet, Thomas Cuisset, Giuseppe De Luca, Leonardo De Luca, Andrew Farb, Francesco Franchi, C. Michael Gibson, Joo‐Yong Hahn, Myeong‐Ki Hong, Stefan James, Adnan Kastrati, Takeshi Kimura, Pedro A. Lemos, Renato D. Lópes, Adrian Magee, Ryosuke Matsumura, Shuichi Mochizuki, Michelle L. O’Donoghue, Naveen L. Pereira, Sunil V. Rao, Fabiana Rollini, Yuko Shirai, Dirk Sibbing, Peter C. Smits, Philippe Gabríel Steg, Robert F. Storey, Jurriën M. ten Berg, Marco Valgimigli, Pascal Vranckx, Hirotoshi Watanabe, Stephan Windecker, Patrick W. Serruys, Robert W. Yeh, Marie‐Claude Morice, Dominick J. Angiolillo

Bibliographic record

VenueCirculation · 2023
Typereview
Languageen
FieldMedicine
TopicAntiplatelet Therapy and Cardiovascular Diseases
Canadian institutionsInstitute of Infection and Immunity
FundersDuke Clinical Research InstituteNational Institutes of HealthCytoSorbents EuropeDaiichi Sankyo EuropeServierNational Evidence-based Healthcare Collaborating AgencyGlaxoSmithKlineConselho Nacional de Desenvolvimento Científico e TecnológicoMedicines CompanyCanada Excellence Research Chairs, Government of CanadaBelvoir Media GroupDaiichi-SankyoAstraZenecaAmarin CorporationBoston Scientific CorporationIntas PharmaceuticalsBristol-Myers SquibbEli Lilly and CompanyCSL BehringAlnylam PharmaceuticalsMicroPortIdorsia PharmaceuticalsAbbott VascularBrigham and Women's HospitalKowa CompanySanofiAmgenPfizer
KeywordsMedicinePercutaneous coronary interventionCoronary artery diseaseAcute coronary syndromeInternal medicineCardiologyMyocardial infarctionClopidogrelIntensive care medicineDisease

Abstract

fetched live from OpenAlex

Antiplatelet therapy is the mainstay of pharmacologic treatment to prevent thrombotic or ischemic events in patients with coronary artery disease treated with percutaneous coronary intervention and those treated medically for an acute coronary syndrome. The use of antiplatelet therapy comes at the expense of an increased risk of bleeding complications. Defining the optimal intensity of platelet inhibition according to the clinical presentation of atherosclerotic cardiovascular disease and individual patient factors is a clinical challenge. Modulation of antiplatelet therapy is a medical action that is frequently performed to balance the risk of thrombotic or ischemic events and the risk of bleeding. This aim may be achieved by reducing (ie, de-escalation) or increasing (ie, escalation) the intensity of platelet inhibition by changing the type, dose, or number of antiplatelet drugs. Because de-escalation or escalation can be achieved in different ways, with a number of emerging approaches, confusion arises with terminologies that are often used interchangeably. To address this issue, this Academic Research Consortium collaboration provides an overview and definitions of different strategies of antiplatelet therapy modulation for patients with coronary artery disease, including but not limited to those undergoing percutaneous coronary intervention, and consensus statements on standardized definitions.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Review · Consensus signal: none
Teacher disagreement score0.643
Threshold uncertainty score0.706

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.080
GPT teacher head0.362
Teacher spread0.281 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations165
Published2023
Admission routes2
Has abstractyes

Explore more

Same venueCirculationSame topicAntiplatelet Therapy and Cardiovascular DiseasesFrench-language works237,207